NYSE:IBIO

Ibio Stock News

Healthcare > Biotechnology

Buy IBIO

*Your capital is at risk

$1.84

+0.0800 (+4.55%)

At Close: Jun 03, 2026

iBio Highlights Unveiling Of FastGlycaneering Service

12:00am, Tuesday, 10'th Dec 2019

IBio shares are trading lower. This could potentially be profit taking after the stock rallied approximately 163% over the past 4 trading sessions. NOTE: The stock is trading on ~9X above-average volume.

12:00am, Thursday, 05'th Dec 2019

IBio shares are trading higher on continued momentum after the company joined the manufacturing USA's tissue Biofabrication initiative.

12:00am, Wednesday, 04'th Dec 2019

IBio shares are trading higher after the company joined the manufacturing USA's tissue Biofabrication initiative.

12:00am, Tuesday, 03'rd Dec 2019

IBio shares are trading lower. Not seeing any news to justify the price action.

12:00am, Tuesday, 19'th Nov 2019

IBio shares are trading lower after the company reported its quarterly earnings report.

12:00am, Friday, 15'th Nov 2019

IBio shares are trading higher on seemingly no company-specific news.

12:00am, Thursday, 14'th Nov 2019

IBio shares are trading lower after the company announced the pricing of an underwritten public offering with expected total gross proceeds of approximately $5 million.

12:00am, Friday, 25'th Oct 2019

iBio Reported Notice Of Noncompliance Notice From NYSE American

12:00am, Tuesday, 22'nd Oct 2019

IBio shares are trading lower after the company announced it filed for a $30 million equity offering.

12:00am, Thursday, 29'th Aug 2019

64 Biggest Movers From Yesterday

12:00am, Wednesday, 28'th Aug 2019

IBio shares are trading higher after the company announced it has expanded its business collaboration with CC-Pharming by granting it an exclusive, royalty-bearing commercial license to Rituximab for the territory of China.

12:00am, Tuesday, 27'th Aug 2019

iBio shares are trading higher after the company announced an expansion of its collaboration with CC-Pharming by granting it an exclusive, royalty-bearing commercial license to rituximab.

Ibio Stock News

iBio Highlights Unveiling Of FastGlycaneering Service

IBio shares are trading lower. This could potentially be profit taking after the stock rallied approximately 163% over the past 4 trading sessions. NOTE: The stock is trading on ~9X above-average volume.

IBio shares are trading higher on continued momentum after the company joined the manufacturing USA's tissue Biofabrication initiative.

IBio shares are trading higher after the company joined the manufacturing USA's tissue Biofabrication initiative.

IBio shares are trading lower. Not seeing any news to justify the price action.

IBio shares are trading lower after the company reported its quarterly earnings report.

IBio shares are trading higher on seemingly no company-specific news.

IBio shares are trading lower after the company announced the pricing of an underwritten public offering with expected total gross proceeds of approximately $5 million.

iBio Reported Notice Of Noncompliance Notice From NYSE American

IBio shares are trading lower after the company announced it filed for a $30 million equity offering.

64 Biggest Movers From Yesterday

IBio shares are trading higher after the company announced it has expanded its business collaboration with CC-Pharming by granting it an exclusive, royalty-bearing commercial license to Rituximab for the territory of China.

iBio shares are trading higher after the company announced an expansion of its collaboration with CC-Pharming by granting it an exclusive, royalty-bearing commercial license to rituximab.

A Look At Benzinga Pro's Most-Searched Tickers For August 21, 2019

Top Fintech Company